Efficient vaccination by intradermal or intramuscular inoculation of plasmid DNA expressing hepatitis B surface antigen under desmin promoter/enhancer control

Vaccine

Volumn 18, Issue 22, 2000, Pages 2337-2344

  Kwissa, Marcin ^a   Von Kampen, Jan ^a   Zurbriggen, Rinaldo ^b   Glück, Reinhard ^b   Reimann, Jörg ^a   Schirmbeck, Reinhold ^a  

^a UNIVERSITY OF ULM   (Germany)

^b Berna Biotech AG   (Switzerland)

Author keywords

CTL priming; Desmin promoter; DNA vaccination; HBsAg vaccine

Indexed keywords

DESMIN; DNA VACCINE; HEPATITIS B SURFACE ANTIGEN; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; PLASMID DNA;

ANIMAL CELL; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIGEN EXPRESSION; ARTICLE; CELL SPECIFICITY; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE CONSTRUCT; GENE GUN; HAMSTER; HUMORAL IMMUNITY; IMMUNIZATION; IN VITRO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; SPECIES DIFFERENCE; T LYMPHOCYTE; TECHNIQUE; TH1 CELL;

EID: 0034055751     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(00)00030-X     Document Type: Article

References (26)

1. Ertl H.C., Xiang Z. Novel vaccine approaches. J. Immunol. 156:1996;3579-3582.
2. Koprowski H., Weiner D.B. DNA vaccination/genetic vaccination. Curr. Top. Microbiol. Immunol. 226:1998;V-XIII.
3. Levitsky H.I. Accessories for naked DNA vaccines. Nat. Biotechnol. 15:1997;619-620.
4. Ulmer J.B., Sadoff J.C., Liu M.A. DNA vaccines. Curr. Opin. Immunol. 8:1996;531-536.
5. Gao J., Li Z., Paulin D. A novel site, Mt, in the human desmin enhancer is necessary for maximal expression in skeletal muscle. J. Biol. Chem. 273:1998;6402-6409.
6. Li Z., Marchand P., Humbert J., Babinet C., Paulin D. Desmin sequence elements regulating skeletal muscle-specific expression in transgenic mice. Development. 117:1993;947-959.
7. Li Z.L., Paulin D. High level desmin expression depends on a muscle-specific enhancer. J. Biol. Chem. 266:1991;6562-6570.
8. Böhm W., Kuhröber A., Paier T., Mertens T., Reimann J., Schirmbeck R. DNA vector constructs that prime hepatitis B surface antigen-specific cytotoxic T lymphocytes and antibody responses in mice after intramuscular injection. J. Immunol. Meth. 193:1996;29-40.
9. Davis H.L., Schirmbeck R., Reimann J., Whalen R.G. DNA-mediated immunization in mice induces a potent MHC class I-restricted cytotoxic T lymphocyte response to Hepatitis B virus surface antigen. Hum. Gene Ther. 6:1995;1447-1456.
10. Schirmbeck R., Böhm W., Ando K.-I., Chisari F.V., Reimann J. Nucleic acid vaccination primes hepatitis B surface antigen-specific cytotoxic T lymphocytes in nonresponder mice. J. Virol. 69:1995;5929-5934.
11. Böhm W., Schirmbeck R., Elbe A., Melber K., Diminsky D., Kraal G., Van Rooijen N., Barenholz Y., Reimann J. Exogenous hepatitis B surface antigen particles processed by dendritic cells or macrophages prime murine MHC class I-restricted cytotoxic T lymphocytes in vivo. J. Immunol. 155:1995;3313-3321.
12. Schirmbeck R., Böhm W., Melber K., Reimann J. Processing of exogenous heat-aggregated (denatured) or particulate (native) hepatitis B surface antigen for class I-restricted epitope presentation. J. Immunol. 155:1995;4676-4684.
13. + cytotoxic T lymphocyte responses in vivo. J. Immunol. 152:1994;1110-1119.
14. Schirmbeck R., Melber K., Mertens T., Reimann J. Selective stimulation of murine cytotoxic T cell and antibody responses by particulate or monomeric hepatitis B virus surface (S) antigen. Eur. J. Immunol. 24:1994;1088-1096.
15. Qiu P., Ziegelhoffer P., Sun J., Yang N.S. Gene gun delivery of mRNA in situ results in efficient transgene expression and genetic immunization. Gene Ther. 3:1996;262-268.
16. Eisenbraun M.D., Fuller D.H., Haynes J.R. Examination of parameters affecting the elicitation of humoral immune responses by particle bombardment-mediated genetic immunization. DNA Cell Biol. 12:1993;791-797.
17. Feltquate D.M., Heaney S., Webster R.G., Robinson H.L. Different T helper cell types and antibody isotypes generated by saline and gene gun DNA immunization. J. Immunol. 158:1997;2278-2284.
18. Pertmer T.M., Eisenbraun M.D., McCabe D., Prayaga S.K., Fuller D.H., Haynes J.R. Gene gun-based nucleic acid immunization elicitation of humoral and cytotoxic T lymphocyte responses following epidermal delivery of nanogram quantities of DNA. Vaccine. 13:1995;1427-1430.
19. Prayaga S.K., Ford M.J., Haynes J.R. Manipulation of HIV-1 gp120-specific immune responses elicited via gene gun-based DNA immunization. Vaccine. 15:1997;1349-1352.
20. Torres C.A., Iwasaki A., Barber B.H., Robinson H.L. Differential dependence on target site tissue for gene gun and intramuscular DNA immunizations. J. Immunol. 158:1997;4529-4532.
21. Vahlsing H.L., Yankauckas M.A., Sawdey M., Gromkowski S.H., Manthorpe M. Immunization with plasmid DNA using a pneumatic gun. J. Immunol. Meth. 175:1994;11-22.
22. Simon M.M., Gern L., Hauser P., Zhong W., Nielsen P.J., Kramer M.D., Brenner C., Wallich R. Protective immunization with plasmid DNA containing the outer surface lipoprotein A gene of Borrelia burgdorferi is independent of an eukaryotic promoter. Eur. J. Immunol. 26:1996;2831-2840.
23. Zhong W., Wiesmuller K.H., Kramer M.D., Wallich R., Simon M.M. Plasmid DNA and protein vaccination of mice to the outer surface protein A of Borrelia burgdorferi leads to induction of T helper cells with specificity for a major epitope and augmentation of protective IgG antibodies in vivo. Eur. J. Immunol. 26:1996;2749-2757.
24. + T cells after gene gun immunization. J. Exp. Med. 188:1998;1075-1082.
25. Mahvi D.M., Sheehy M.J., Yang N.S. DNA cancer vaccines: a gene gun approach. Immunol. Cell Biol. 75:1997;456-460.
26. Yang N.S., Sun W.H. Gene gun and other non-viral approaches for cancer gene therapy. Nature Med. 1:1995;481-483.